Current News

Contact | Print version | PDF version | Send article | RSS feed

Kinaxo Biotechnologies Awarded Grant to Expand Applications for its Chemical Proteomics Platform

28 Jul 2008 - Kinaxo Biotechnologies GmbH announced that it was awarded a 575,000 Euro grant by the Bavarian Ministry of Economic Affairs, Infrastructure, Transport and Technology to help expand the applications for its chemical proteomics platform. Chemical proteomics enables a comprehensive assessment of the native cellular proteome interactions and selectivity of small molecule drug candidates. Kinaxo will use the funding to demonstrate how its platform can be employed to identify the native protein targets of compounds found in cell-based ('phenotypic') drug discovery screens.
 
Dr. Andreas Jenne, Kinaxo's CEO commented: "This funding will allow us to significantly expand the scope and utility of our chemical proteomics capability, helping to demonstrate further valuable applications for broad adoption in the field of small molecule drug development."